Publications by authors named "Betty Schaub"

To date, few studies have systematically characterized microarray gene expression signal performance with degraded RNA from fixed (FFPE) in comparison with intact RNA from unfixed fresh-frozen (FF) specimens. RNA was extracted and isolated from paired tumor and normal samples from both FFPE and FF kidney, lung, and colon tissue specimens and microarray signal dynamics on both the raw probe and probeset level were evaluated. A contrast metric was developed to directly compare microarray signal derived from RNA extracted from matched FFPE and FF specimens.

View Article and Find Full Text PDF

PURPOSE Ewing sarcoma family tumors (ESFTs) exhibit chromosomal translocations that lead to the creation of chimeric fusion oncogenes. Combinatorial diversity among chromosomal breakpoints produces varying fusions. The type 1 EWS-FLI1 transcript is created as a result of fusion between exons 7 of EWS and 6 of FLI1, and retrospective studies have reported that type 1 tumors are associated with an improved outcome.

View Article and Find Full Text PDF

Background: Affymetrix exon arrays offer scientists the only solution for exon-level expression profiling at the whole-genome scale on a single array. These arrays feature a new chip design with no mismatch probes and a radically new random primed protocol to generate sense DNA targets along the entire length of the transcript. In addition to these changes, a limited number of validating experiments and virtually no experimental data to rigorously address the comparability of all-exon arrays with conventional 3'-arrays result in a natural reluctance to replace conventional expression arrays with the new all-exon platform.

View Article and Find Full Text PDF

The experimental spike-in studies of microarray hybridization conducted by Affymetrix demonstrate a nonlinear response of fluorescence intensity signal to target concentration. Several theoretical models have been put forward to explain these data. It was shown that the Langmuir adsorption isotherm recapitulates a general trend of signal response to concentration.

View Article and Find Full Text PDF
Article Synopsis
  • Several studies indicate that COX-2 inhibitors, particularly celecoxib, might help prevent breast cancer due to their low toxicity as chemopreventive agents.
  • Celecoxib has been shown to inhibit growth and induce apoptosis in breast epithelial cells by significantly increasing the expression of insulin-like growth factor binding protein-3 (IGFBP-3), a protein that blocks cancer cell proliferation.
  • The findings suggest that the mechanism behind celecoxib's chemopreventive effects involves enhancing IGFBP-3 levels, which may lower the risk of breast cancer linked to IGF-I signaling.
View Article and Find Full Text PDF